EYE CARE IN BELGIUM

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Eye Care Players Push for Self-medication

Artificial Tears Should Fare Better Than Allergy Eye Care and "sensitive" Products

Eye Health Supplements To Remain Non-negligible Indirect Competitors

Competitive Landscape

Théa Pharma Leads Eye Care

Disparate Performance Due To Short-term Success

Testing Proves Effective Strategy

Category Data

Table 1 Sales of Eye Care by Category: Value 2013-2018

Table 2 Sales of Eye Care by Category: % Value Growth 2013-2018

Table 3 Sales of Standard Eye Care by Format: % Value 2013-2018

Table 4 Sales of Standard Eye Care by Positioning: % Value 2013-2018

Table 5 NBO Company Shares of Eye Care: % Value 2014-2018

Table 6 LBN Brand Shares of Eye Care: % Value 2015-2018

Table 7 Forecast Sales of Eye Care by Category: Value 2018-2023

Table 8 Forecast Sales of Eye Care by Category: % Value Growth 2018-2023

Executive Summary

Differing Fates for OTC Products and Other Consumer Health

Non-otc Products Also Have Their Own Constraints

Generic, Medium-sized And/or Local Manufacturers Fare Better Than Ethical Multinationals

Movement Within Distribution

Manufacturers Remain Wary of Future Legislation

Market Indicators

Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 10 Life Expectancy at Birth 2013-2018

Market Data

Table 11 Sales of Consumer Health by Category: Value 2013-2018

Table 12 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 13 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 14 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018

Table 16 Distribution of Consumer Health by Format: % Value 2013-2018

Table 17 Distribution of Consumer Health by Format and Category: % Value 2018

Table 18 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Summary 1 OTC: Switches

Definitions

Sources

Summary 2 Research Sources

After years of doubts, manufacturers believe self-medication should really progress in eye care. In 2017 and, to a lesser extent, 2018, there was an atypically sluggish increase in sales due to the slower performance by allergy eye care and some other niche areas. However, eye care should remain one of the most dynamic performers in OTC products during the forecast period. All the endeavours by players to reassure and educate consumers and fight against prejudices are beginning to find success a...

Euromonitor International's Eye Care in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Allergy Eye Care, Standard Eye Care.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Eye Care market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.